Invest A/s Lundbeckfond's Net Worth
$17.7 Million
Who is Invest A/s Lundbeckfond?
Invest A/s Lundbeckfond has an estimated net worth of $17.7 Million. This is based on reported shares across multiple companies, which include Lexeo Therapeutics, Inc., Celladon Corp, IO Biotech, Inc., Spero Therapeutics, Inc., Trevi Therapeutics, Inc., scPharmaceuticals Inc., and IMARA Inc..
SEC CIK
Invest A/s Lundbeckfond's CIK is 0001591046
Past Insider Trading and Trends
2023 was Invest A/s Lundbeckfond's most active year for acquiring shares with 5 total transactions. Invest A/s Lundbeckfond's most active month to acquire stocks was the month of October. 2014 was Invest A/s Lundbeckfond's most active year for disposing of shares, totalling 3 transactions. Invest A/s Lundbeckfond's most active month to dispose stocks was the month of October. 2021 saw Invest A/s Lundbeckfond paying a total of $29,999,998.00 for 6,049,452 shares, this is the most they've acquired in one year. In 2014 Invest A/s Lundbeckfond cashed out on 19,666,185 shares for a total of $148,840.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Lexeo Therapeutics, Inc. (LXEO) Snapshot price: $10.9
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 1.84M |
$11.00 |
—
| 1.84M |
Nov 7
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Celladon Corp (EIGR) No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 1.75M |
$8.00 |
—
| 1.75M |
Feb 4
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
IO Biotech, Inc. (IOBT) Snapshot price: $0.843
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| +130.61% | 7.9M |
$1.90 | $15,012,344.60 | 13.95M |
Aug 9
| |||
Form 4
|
∞
| 6.05M |
$14.00 |
—
| 6.05M |
Nov 9
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Spero Therapeutics, Inc. (SPRO) Snapshot price: $1.3101
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Trevi Therapeutics, Inc. (TRVI) Snapshot price: $2.95
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 1.15M |
$10.00 |
—
| 1.15M |
May 9
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |